Literature DB >> 1354203

Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants.

N Gross1, S Favre, D Beck, M Meyer.   

Abstract

The expression of cellular adhesion molecules (CAM) involved in cell adhesion and immune recognition was measured on neuroblastoma tissue samples, on a neuroblastoma (NB) cell line, SK-N-SH, and on 3 phenotypically different variants, SH-SY5Y, SH-EP, SH-IN, representing neuronal, Schwannian/glial or intermediate NB-cell types. Immunohistochemical analysis of CAM expression by NB and related tumors at different stages of differentiation revealed a co-expression of several CAM (ICAM-1/CD54, LFA-3, VLA-2 and HLA-ABC) associated with low stages and more highly differentiated NB tumors and peripheral neuroepitheliomas (PN). In contrast, N-CAM was uniformly expressed on all NB tumors. Flow cytometric analysis of CAM surface expression by SK-N-SH and variant cells revealed highly variable phenotypes. Expression of ICAM-1, LFA-3, VLA-2 and HLA-ABC molecules was associated with the epithelial cell type represented by the SH-EP variant. In contrast, low expression of these molecules and high expression of N-CAM was associated with the neuronal SH-SY5Y cells. Exposure of the NB cells to differentiation inducers (retinoic acid, 5'-bromodeoxyuridine and phorbol esters) and cytokines (tau-interferon, alpha-tumor necrosis factor) resulted in a variable up-regulation of the expression of all CAMs, except N-CAM, regardless of the type of differentiation induced. In an attempt to establish a link between the pattern of expression of CAM on NB cells and their susceptibility to natural killer (NK) or lymphokine-activated killer (LAK) cell lysis, the analysis revealed that NB cells expressing CAM and a differentiated phenotype were less susceptible to NK lysis, but no difference in the sensitivity of the NB cell types to LAK effectors was observed. Treatment of NB target cells with cytokines or PMA decreased their susceptibility to NK and LAK lysis, while induction of differentiation with RA or BUdR resulted in no changes in the sensitivity to NK and LAK lysis. In conclusion, expression of HLA-ABC and several co-regulated CAMs was shown to be associated with a differentiated phenotype in NB, with an overall decreased sensitivity to NK/LAK effector cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354203     DOI: 10.1002/ijc.2910520116

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Bottom up proteomics reveals novel differentiation proteins in neuroblastoma cells treated with 13-cis retinoic acid.

Authors:  Effie G Halakos; Andrew J Connell; Lisa Glazewski; Shuo Wei; Robert W Mason
Journal:  J Proteomics       Date:  2019-08-28       Impact factor: 4.044

2.  Retinoic acid influences neuronal migration from the ganglionic eminence to the cerebral cortex.

Authors:  James E Crandall; Timothy Goodman; Deirdre M McCarthy; Gregg Duester; Pradeep G Bhide; Ursula C Dräger; Peter McCaffery
Journal:  J Neurochem       Date:  2011-10-11       Impact factor: 5.372

3.  PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma.

Authors:  Tiziana Bachetti; Daniela Di Paolo; Simona Di Lascio; Valentina Mirisola; Chiara Brignole; Marta Bellotti; Irene Caffa; Chiara Ferraris; Michele Fiore; Diego Fornasari; Roberto Chiarle; Silvia Borghini; Ulrich Pfeffer; Mirco Ponzoni; Isabella Ceccherini; Patrizia Perri
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

4.  Differential expression of beta 1, beta 3 and beta 4 integrins in sarcomas of the small, round, blue cell category.

Authors:  T Barth; P Möller; G Mechtersheimer
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Gamma interferon transduced 9L gliosarcoma. Cytokine gene therapy and its relevance to cellular therapy with alloreactive cytotoxic T lymphocytes.

Authors:  David B Paul; Susana B Read; Nisha V Kulprathipanja; German G Gomez; B K Kleinschmidt-DeMasters; Patric M Schiltz; Carol A Kruse
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

6.  Transfection of the mouse ICAM-1 gene into murine neuroblastoma enhances susceptibility to lysis, reduces in vivo tumorigenicity and decreases ICAM-2-dependent killing.

Authors:  E Katsanis; M A Bausero; H Xu; P J Orchard; Z Xu; R S McIvor; A A Brian; B R Blazar
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

7.  C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma.

Authors:  Stefan Salcher; Judith Hagenbuchner; Kathrin Geiger; Maximilian A Seiter; Johannes Rainer; Reinhard Kofler; Martin Hermann; Ursula Kiechl-Kohlendorfer; Michael J Ausserlechner; Petra Obexer
Journal:  Mol Cancer       Date:  2014-09-28       Impact factor: 27.401

8.  C10ORF10/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy.

Authors:  S Salcher; M Hermann; U Kiechl-Kohlendorfer; M J Ausserlechner; P Obexer
Journal:  Mol Cancer       Date:  2017-05-25       Impact factor: 27.401

9.  Close interactions between mesenchymal stem cells and neuroblastoma cell lines lead to tumor growth inhibition.

Authors:  Giovanna Bianchi; Fabio Morandi; Michele Cilli; Antonio Daga; Chiara Bocelli-Tyndall; Claudio Gambini; Vito Pistoia; Lizzia Raffaghello
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

10.  Repaglinide Silences the FOXO3/Lumican Axis and Represses the Associated Metastatic Potential of Neuronal Cancer Cells.

Authors:  Stefan Salcher; Gilles Spoden; Julia M Huber; Georg Golderer; Herbert Lindner; Michael J Ausserlechner; Ursula Kiechl-Kohlendorfer; Kathrin Geiger; Petra Obexer
Journal:  Cells       Date:  2019-12-18       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.